{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:07:33Z","timestamp":1762078053550},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5631,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1046\/j.1365-2133.2000.03432.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:25:46Z","timestamp":1047360346000},"page":"808-811","source":"Crossref","is-referenced-by-count":62,"title":["Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel"],"prefix":"10.1093","volume":"142","author":[{"given":"C-Y.","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G-H.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-C.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0305-7372(93)90010-O","article-title":"The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).","volume":"19","author":"Pazdur","year":"1993","journal-title":"Cancer Treat Rev"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0305-7372(95)90030-6","article-title":"Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.","volume":"21","author":"Pronk","year":"1995","journal-title":"Cancer Treat Rev"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archderm.1995.01690140086015","article-title":"Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent.","volume":"131","author":"Zimmerman","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.1994.12.7.1458","article-title":"Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.","volume":"12","author":"Tomiak","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.1998.16.6.2164","article-title":"Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.","volume":"16","author":"Hainsworth","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0959-8049(97)85302-6","article-title":"Phase I study of weekly docetaxel (Taxotere) in heavily pretreated breast cancer patients.","volume":"33","author":"L\u00fcck","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB7|cit7","first-page":"113","article-title":"Activity of weekly Taxotere (TXT) in patients with metastatic breast cancer.","volume":"17","author":"L\u00f6effler","year":"1998","journal-title":"Proc ASCO"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB8|cit8","first-page":"127","article-title":"Weekly docetaxel (Taxotere) for metastatic breast cancer: a phase II trial.","volume":"18","author":"Burstein","year":"1999","journal-title":"Proc ASCO"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB9|cit9","first-page":"134","article-title":"A phase II trial of weekly docetaxel in patients with advanced metastatic breast cancer-preliminary results.","volume":"18","author":"Mey","year":"1999","journal-title":"Proc ASCO"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB10|cit10","first-page":"601","article-title":"Phase II trials of weekly docetaxel in the treatment of patients who are elderly or medically compromised: a Minnie Pearl research network study.","volume":"18","author":"Miranda","year":"1999","journal-title":"Proc ASCO"},{"key":"10.1046\/j.1365-2133.2000.03432.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000018132","article-title":"Nail changes secondary to docetaxel (Taxotere).","volume":"198","author":"Correia","year":"1999","journal-title":"Dermatology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03432.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:28:51Z","timestamp":1676377731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/142\/4\/808\/6690437"}},"subtitle":["FIXED ERYTHRODYSAESTHESIA PLAQUE DUE TO DOCETAXEL"],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03432.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}